Latest News

Page 20 of 26« First...10...1819202122...Last »

September 14, 2013

High Dose Stem Cell Transplant Performed

Posted in: Latest News, Research and Developments

Stem Cells (STEM) has announced the first patient to receive a high dose of one million purified human neural stem cells (HuCNS-SC®) in their Phase 1/2 clinical trial. This followed an independent review by the Data Safety Monitoring Committee, which found no safety issues with proceeding to the high dose. The 16-patient trial is designed to evaluate the
read more »

September 14, 2013

Prevent Blindness America Launches New Online Resource, “Living Well with Low Vision”

Posted in: Latest News

To directly address the needs of those with low vision and their caregivers, Prevent Blindness America has launched a new online resource: “Living Well with Low Vision”. The goal of the new website is to make it as easy as possible for people to educate themselves about loss of vision, to meet the daily challenges
read more »

September 12, 2013

New Stem Cell Eye Treatment Study Beginning

Posted in: Latest News, Research and Developments

(Updated March 12, 2017) MD Stem Cells has announced a new and extensive stem cell study  to determine effectiveness of stem cells in ophthalmic disease. The company has been named collaborator for the new Stem Cell Ophthalmology Treatment Study (SCOTS), being conducted in Florida. Conditions eligible for the new study include retinal diseases such as age-related
read more »

September 5, 2013

Eylea Approved in Europe for CRVO

Posted in: Latest News

Regeneron Pharmaceuticals’ Eylea (aflibercept) treatment for central retinal vein occlusion (CRVO) has been approved by the European Commission. Eylea was approved in the United States for the treatment of neovascular (wet) age-related macular degeneration (AMD) in 2011, and for macular edema following CRVO in 2012. The drug has also been approved in Europe, Japan, Australia,
read more »

September 2, 2013

Statin Therapy Lowers Risk of Cataracts

Posted in: Latest News, Research and Developments

by Dan Roberts Statin therapy has been shown to reduce inflammation in the retina, but there has been some concern about cataract development for those who use the drugs. In a press conference at the European Society of Cardiology meeting, Aug 30, 2013, John B. Kostis, MD (UMDNJ-Robert Wood Johnson Medical School, New Brunswick, N.J.)
read more »

August 29, 2013

“As-Needed” Injections Are an Option for Wet AMD

Posted in: Latest News, Research and Developments, Therapies, Treatments, and Procedures

Two-year results from the recently-completed HARBOR trial showed that some patients with wet AMD fare as well from Lucentis (ranibizumab) injections on an as-needed basis compared to a monthly basis. The original Lucentis trial recommended monthly dosing until the eye stabilized. The follow-up study, however, found that 93% of patients responded well with an average
read more »

August 27, 2013

Lampalizumab Effective in Slowing Progression of Dry AMD

Posted in: Latest News, Research and Developments

Roche Pharmaceutical has announced positive phase II results from their MAHALO phase II study of lampalizumab (aka anti-factor D). The study showed a 20.4 percent reduction in progression of advanced dry macular degeneration (geographic atrophy) at 18 months. Lampalizumab is designed to inhibit Complement Factor D, a protein that is part of the alternative complement
read more »

August 22, 2013

Support Groups Can Improve Quality of Life

Posted in: Daily Living, Latest News, Research and Developments

by Dan Roberts Researchers have found that facilitated patient support groups can significantly improve visual quality of life (VQoL) for visually impaired people. Twenty-nine groups of up to six patients each were recruited for participation in a “peer group emotional support service” facilitated by trained counselors for a period of six months. Their responses to
read more »

August 21, 2013

Improving Autophagy Function Reduces Drusen

Posted in: Latest News, Research and Developments

by Dan Roberts Researchers at the University of Eastern Finland have discovered that a cleaning mechanism in the center of the retina may be faulty in people who develop age-related macular degeneration (AMD). A cleaning process called autophagy helps clear cellular waste deposits (drusen) that can build up in the retinal tissue. If autophagy diminishes,
read more »

August 19, 2013

Medicare Approves Payment for Argus® II Retinal Prosthesis System

Posted in: Latest News, Therapies, Treatments, and Procedures

Payments Will Facilitate Beneficiary Access to Argus II in both Inpatient and Outpatient Settings  Sylmar, CA- August 15, 2013—Second Sight Medical Products, Inc. today announced that The Argus® II Retinal Prosthesis System (Argus II) has been approved by the Centers for Medicare and Medicaid Services (CMS) beginning October 1, 2013.  These payments are designed to support
read more »

Page 20 of 26« First...10...1819202122...Last »

Custom Wordpress design and web development by Jeff Roberts Web Design

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann